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http://dx.doi.org/10.1016/j.pedneo.2
1875-9572/Copyright ª 2014, TaiwanBackground: This study aimed to evaluate the impact of small-for-gestational-age (SGA) on
mortality and morbidity in very-low-birth-weight (VLBW) infants.
Methods: We conducted a retrospective cohort study on VLBW infants registered at the Prema-
ture Baby Foundation of Taiwan between 2007 and 2011. All 21 neonatal departments in Taiwan
participated in the data collection, and a total of 4636 VLBW infants were registered during the
study period. The SGA group (nZ 560) was selected from the database on the basis of birth
weight below the 10th percentile for gestational age, whereas the appropriate-weight-for-gesta-
tional-age (AGA) group (nZ 1120) included infants randomly selected via incidence density sam-
pling with a 2:1 match for each SGA case. The association of SGA with individual outcome
variables including mortality, respiratory distress syndrome, necrotizing enterocolitis, retinop-
athy of prematurity (ROP), intraventricular hemorrhage, periventricular leukomalacia, and
bronchopulmonary dysplasia (BPD) was evaluated after adjustment for potential confounders.
Results: The SGA group was associated with increased risks of mortality [odds ratio (OR) 1.89;
95% confidence interval (CI) 1.39‒2.58], severe ROP (OR 1.56; 95% CI 1.13e2.14), and BPD (OR
2.08; 95% CI 1.58e2.75) compared to the AGA group. Further subgroup analysis showed that
SGA had significant effects on mortality in the VLBW infants with a gestational age of 24e29of Pediatrics, Shin-Kong Wu Ho-Su Memorial Hospital, Number 95, Wen Chang Road, Shih Lin District,
com.tw (S.-C. Mu).
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102 L.-Y. Tsai et alweeks, as well as on BPD in those with a gestational age of 27e32 weeks. By contrast, the asso-
ciation of SGAwith severe ROP was only significant in the VLBW infants with a gestational age of
27e29 weeks.
Conclusion: Our data provide evidence that SGA may be associated with increased risks of
neonatal mortality, ROP, and BPD in VLBW infants.
Copyright ª 2014, Taiwan Pediatric Association. Published by Elsevier Taiwan LLC. All rights
reserved.1. Introduction
Small-for-gestational-age (SGA) infants represent a signifi-
cant percentage of infants admitted to Neonatal Intensive
Care Units. SGA is associated with an increased risk of
spontaneous and iatrogenic preterm delivery.1,2 However,
its impact on prematurity-associated neonatal morbidity
has been disputed due to inconsistent results in the liter-
ature. Although some studies showed that SGA was an
adverse risk factor of neonatal clinical outcomes,3,4 others
suggested a lower risk for respiratory distress syndrome
(RDS) in SGA infants compared to appropriate-weight-for
gestational age (AGA) infants.5e7 Similarly, the reported
associations between SGA and risks of intracranial hemor-
rhage and periventricular leucomalacia (PVL) vary from one
study to another.8,9
It has been speculated that these discrepancies may be
attributed to differences in study methodologies and sam-
ple characteristics, such as the definitions of SGA, sample
sizes, range of gestational ages, and birth weights of study
populations. In addition, AGA comparison groups often
differed in either birth weights or gestational age; it was
unclear whether the clinical outcome resulted from a
shorter gestation period or impaired prenatal growth. To
address this issue, some studies have compared the clinical
outcomes in SGA infants with those in gestational age-
matched AGA infants.10,11
To evaluate the association of SGA with neonatal mor-
tality and morbidity accurately, we conducted a matched
group study to avoid selection bias and compared the
neonatal outcomes in SGA and AGA very-low-birth-weight
(VLBW) infants matched for gestational age.
2. Methods
2.1. Ethics statement
Written informed consent was obtained from designated
relatives of each infant. The study was approved by the
Institutional Review Boards of each participating hospital,
including the National Taiwan University Hospital, Chang
Gung Memorial Hospital, China Medical University Hospi-
tal, National Cheng Kung University Hospital, Tri-Service
General Hospital, Chung Shan Medical University Hospital,
Shin Kong Wu Ho-Su Memorial Hospital, and Kaohsiung
Medical University Chung-Ho Memorial Hospital, as well as
the Joint Institutional Review Board of the other
hospitals.2.2. Participants
A total of 4636 VLBW infants born with a birth weight below
1501 g were registered in the database of the Premature
Baby Foundation of Taiwan between 2007 and 2011. All 21
hospitals located across the island of Taiwan participated in
the data collection. In addition to neonatal histories such as
diagnoses, complications during hospitalization, and clin-
ical outcomes from their health records at the time of
discharge, the database also included antenatal and peri-
natal information. Data entry was conducted after death or
discharge of infants from hospital. Patient information
received by the database coordinator was cross checked
with the national birth registry. Exclusion criteria included
congenital anomalies and chromosome anomalies.
Gestational age was determined from maternal dates of
the last menstrual period and the date of embryo transfer
for in vitro fertilization. SGA infants were identified as
having birth weights below the 10th percentile for gesta-
tional age on sex-specific standards,12 whereas AGA infants
were defined as infants’ birth weights between the 10th and
90th percentiles (inclusive) for gestational age. SGAeAGA
match was carried out and SGA infants with two gestation
age-matched AGA cases were selected in our study group.
For each SGA case, two gestation age-matched AGA infants
were randomly selected using the incidence density sam-
pling approach in a 2:1 match.
2.3. Outcome variables
RDS was defined by clinical diagnosis as requiring surfactant
therapy. The extent of intraventricular hemorrhage (IVH)
and necrotizing enterocolitis (NEC) was graded according to
the classification of Papile et al13 and Bell et al,14 respec-
tively. Severe retinopathy of prematurity (ROP) was clas-
sified as Stage 3 to Stage 5 according to the international
classification.15 PVL was diagnosed by echolucent areas or
persistent echogenicity in periventricular areas on coronal
and sagittal views of cranial ultrasounds.16 Bronchopulmo-
nary dysplasia (BPD) was defined as infants requiring oxygen
supplementation at the postconceptional age of 36
weeks.17
2.4. Statistical analysis
The Chi-square test and the Student t test were used to
compare the distributions of categorical variables and
continuous variables between two groups, respectively. For
Figure 1 Flowchart of the study populations. Congenital
anomalies and chromosome anomalies (N Z 188) were
excluded. AGA Z appropriate-weight-for-gestational-age;
SGA Z small-for-gestational-age; VLBW Z very-low-birth-
weight.
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PVL, ROP, and NEC), separate Chi-square tests were per-
formed to compare SGA and AGA infants. A value of
p < 0.05 was taken to be significant. Multiple logistic
regression analysis adjusted for use of antenatal steroids
and sex was performed to relate individual outcome vari-
ables including RDS, IVH, PVL, and ROP to SGA (with the
AGA group as the reference). With adjustment for ante-
natal steroids, sex, sepsis, and the number of days of use of
intermittent positive pressure ventilation (IPPV), multiple
logistic regression was performed to relate BPD to SGA.
With adjustment for antenatal steroids, sex, and the Apgar
score at 5 minutes after birth, multiple logistic regression
was performed to relate neonatal death to SGA. A variable
was considered to be significantly associated with outcome
if the odds ratio (OR) differed from 1.0 and p < 0.05. The
association of SGA with outcome variables was further
examined in subgroup analysis with stratification according
to gestational ages. Statistical analysis was performed using
SAS version 9.2 (SAS Institute, Cary, NC, USA).
3. Results
3.1. Characteristics of the study population
A total of 4448 VLBW infants were enrolled in the study
after congenital anomalies and chromosome anomalies
(n Z 188) were excluded. There were 1454 (33.2%) SGA
infants within the gestational age range of 22e36 weeks
and 2850 (65%) AGA infants within the gestational age range
of 21e32 weeks. After the SGAeAGA match, 560 SGA in-
fants were selected and 1120 AGA infants were randomly
matched with the SGA group according to the gestational
age at birth. The gestational age of the study population
ranged from 22 weeks to 32 weeks (Figure 1).
Table 1 shows the characteristics of VLBW infants clas-
sified as SGA and AGA. The two groups differed in sex, birth
weight, body length, head circumference, and parity. The
SGA group also had lower Apgar scores at 5 minutes after
birth, higher incidence of neonatal sepsis, and longer
duration in use of IPPV. By contrast, no significant differ-
ences were observed between the two groups in use of
antenatal steroids, multiple births, artificial fertilization,
or the incidence of pneumothorax and patent ductus
arteriosus.
3.2. Neonatal mortality and morbidity
In our study population, a total of 247 cases died during
hospitalization. In the SGA group, the causes of death were
RDS (16%), sepsis (7.5%), respiratory failure (60.6%), IVH
(4.1%), BPD (4.3%), and undefined reasons (7.5%). In the
AGA group, the causes of death were RDS (13.1%), sepsis
(9.4%), respiratory failure (55.1%), IVH (8.4%), BPD (2.8%),
and undefined reasons (11.2%). The data on the causes of
death were missing for 44 out of 247 deaths.
Table 2 shows the effects of SGA on the incidence of
various neonatal outcomes including neonatal death, RDS,
ROP, IVH, PVL, NEC, and ROP. The risks of neonatal death,
BPD, and ROP were higher in the SGA group in comparison
to the AGA group. By contrast, there was no statisticallysignificant difference in the risk of RDS, NEC, or PVL be-
tween the groups.
Multiple logistic regression analysis was then conducted
with adjustments for sex and use of antenatal steroids.
Adjusted ORs with a 95% confidence interval (CI) for
different neonatal outcomes are illustrated in Table 3.
Compared to the AGA infants, the SGA infants were asso-
ciated with increased risks of neonatal death (OR 1.89; 95%
CI 1.39e2.58), severe ROP (OR 1.56; 95% CI 1.13e2.14), and
BPD (OR 2.08; 95% CI 1.58e2.75).
Table 4 shows adjusted ORs with a 95% CI for neonatal
mortality and morbidity comparing the SGA and AGA groups
with stratification according to gestational ages. Our
Table 1 Characteristics of very-low-birth-weight infants classified as small-for-gestational-age (SGA) and appropriate-weight-
for-gestational-age (AGA) matched according to gestation.
SGA
N Z 560
AGA
N Z 1120
p
Infant
Gestational age at birth (wk), mean (SD) 28.3 (1.9) 28.3 (1.9)
Sex (% female) 41.3 48.3 0.0062
Birth weight (g), mean (SD) 832.2 (223.4) 1162 (238.5) <0.0001
Head circumference at birth (cm), mean (SD) 24.11 (2.21) 26.02 (2.1) <0.0001
Length at birth (cm), mean (SD) 33.36 (3.66) 37.03 (3.39) <0.0001
Parity (% first born) 62.5 50.1 <0.0001
Multiple birth (%) 30.4 31.0 0.7278
Artificial fertilization (%) 24.1 20.5 0.2164
Antenatal steroid > 2 doses (%) 48.65 48.87 0.9306
Apgar score at 1 minute, median 5 6
Apgar score at 5 minutes, median 7 8
3 (%) 69 (15.3) 116 (11.9) 0.0018
4e6 (%) 247 (54.8) 476 (48.7)
>6 (%) 135 (29.9) 385 (49.4)
Sepsis (%) 106 (19.9) 167 (15.5) 0.02471
Pneumothorax (%)
PDA (%)
IPPV (days of use)
37 (6.7)
227 (44.2)
14.8
76 (6.8)
464 (44.1)
10.4
0.91981
0.97049
0.00015
Mother
Maternal age at birth (yr), mean (SD) 32.4 (4.7) 32.1 (5.1) 0.1346
Maternal nationality (% non-Taiwan) 4.7 4.4 0.8050
Education level (%)
Junior high school or below 9.8 8.1 0.1842
Senior high school 30.5 35.0
University or above 50.7 56.9
IPPV Z intermittent positive pressure ventilation; PDA Z patent ductus arteriosus.
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mortality in the VLBW infants with a gestational age of
24e29 weeks, as well as on BPD in those with a gestational
age of 27e32 weeks. By contrast, the association of SGA
and severe ROP was only significant in the VLBW infants
with a gestational age of 27e29 weeks.Table 2 Incidence of neonatal morbidity and mortality in
very-low-birth-weight infants classified as small-for-gesta-
tional-age (SGA) or appropriate-weight-for-gestational-age
(AGA) matched according to gestation.
SGA
N Z 560
AGA
N Z 1120
p
RDS 256 (45.8) 496 (44.3) 0.5575
NEC 30 (5.4) 48 (4.3) 0.3213
ROP (any grade) 255 (57.2) 483 (49) 0.0041
ROP (Grades IIIeV) 74 (13.29) 100 (8.93) 0.005857
IVH (any grade) 213 (41.3) 387 (36.7) 0.0805
IVH (Grades III, IV) 33 (9.8) 52 (7.5) 0.9488
PVL 22 (4.26) 49 (4.6) 0.7583
BPD 230 (49.4) 306 (30.5) <0.0001
Neonatal death 119 (21.3) 128 (11.4) <0.0001
BPD Z bronchopulmonary dysplasia; IVH Z intraventricular
hemorrhage; NEC Z necrotizing enterocolitis;
PVLZ periventricular leukomalacia; RDSZ respiratory distress
syndrome; ROP Z retinopathy of prematurity.4. Discussion
Our present study provides evidence that SGA may be
associated with an increased risk of mortality in VLBW ne-
onates. Previous studies have shown that the mortality of
infants with a birth weight below the 10th percentile was
higher than that of AGA neonates at all gestational ages up
to 36 weeks.18,19 Similarly, we observed a 1.89-fold in-
crease in mortality in the VLBW infants classified as SGA
with a gestational age of 24e32 weeks compared to the
AGA infants. Interestingly, Bardin et al9 did not observe any
significant difference in mortality between the SGA and
AGA groups; however, their study population was limited to
24e26 weeks’ gestation, and therefore they did not
represent the complete spectrum of premature infants.
Lackman et al1 also showed in a larger population-based
study, that the risk of perinatal death attributed to being
born preterm SGA increased significantly only with a birth
weight below the third percentile, but no differences were
observed in the SGA infants whose birth weights were be-
tween the 3rd and the 10th percentiles. This study popula-
tion included infants from 25 weeks to 40 weeks’ gestation,
and premature delivery was up to 10.5% in the AGA com-
parison group. In the present study, we demonstrated that
a small size at birth (VLBW infants consisting of birth
weights below the 10th percentile for gestational age) may
be associated with a significantly increased risk of neonatal
death.
Table 3 Multivariate-adjusted odds ratio (95% confidence
interval) of outcome variables for the SGA group (the AGA
group was the reference).
OR (95% CI) p
RDS 1.05 (0.86e1.29) * 0.6462
NEC 1.27 (0.80e2.04) * 0.3117
ROP (Stages IIIeV) 1.56 (1.13e2.14) * 0.0069
IVH (Grades III, IV) 0.98 (0.68e1.42) * 0.9115
PVL 0.92 (0.55e1.55) * 0.7594
BPD 2.08 (1.58e2.75) y <0.000001
Neonatal death 1.89 (1.39e2.58) z 0.000056
AGA Z appropriate-weight-for-gestational-age; BPD Z bron-
chopulmonary dysplasia; CI Z confidence interval; IPPV Z
intermittent positive pressure ventilation; IVH Z intraventric-
ular hemorrhage; NEC Z necrotizing enterocolitis; OR Z odds
ratio; PVL Z periventricular leukomalacia; RDS Z respiratory
distress syndrome; ROP Z retinopathy of prematurity;
SGA Z small-for-gestational-age.
* ORs of RDS, NEC, ROP, IVH, and PVL with adjustment for sex
and antenatal steroids.
y OR of BPD with adjustment for sex, antenatal steroids,
sepsis, and number of days of IPPV.
z OR of neonatal death with adjustment for sex, antenatal
steroids, and Apgar score at 5 minutes after birth.
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incidence of BPD in the SGA infants. These findings are
consistent with previous studies showing premature SGA
infants to have an increased incidence of BPD.19e22 The
etiology of BPD is multifactorial, involving factors such as
RDS, duration and degree of ventilator support, higher ox-
ygen concentration exposure of the infant, and chronic
malnutrition. Experimental studies have suggested that
chronic malnutrition induces the deficiency of antioxidants,
which might predispose the infant to BPD.23 Fetal hypox-
emia and acidosis caused by restricted growth may beTable 4 Multivariate-adjusted odds ratio (95% confidence interv
the reference) with stratification according to gestational age.
GA 30e32 weeks
SGA (N ) 178
AGA (N ) 356
RDS * 1.13 (0.71e1.81)
NEC * 2.2 (0.85e5.67)
ROP (Stages IIIeV) * 2.47 (0.83e7.83)
IVH (Grades III, IV) * 2.74 (0.07e1.59)
PVL * 0.33 (0.07e1.59)
BPD z 2.29 (1.28e4.09) y
Neonatal death jj 2.85 (0.84e9.62)
AGA Z appropriate-weight-for-gestational-age; BPD Z bronchopulmo
itive pressure ventilation; IVHZ intraventricular hemorrhage; NECZ
leukomalacia; RDS Z respiratory distress syndrome; ROP Z retinopa
* ORs of RDS, NEC, ROP, IVH, and PVL with adjustment for sex and
y p < 0.05.
z ORs of BPD with adjustment for sex, antenatal steroid, sepsis, an
x p < 0.000005.
jj ORs of neonatal death with adjustment for sex, antenatal steroidinvolved in the release of proinflammatory factors such as
tumor necrosis factor alpha.24
The concept of accelerated lung maturation in response
to “stress” was initially proposed in the 1980s and has been
supported by some studies.6,25 However, in this study, we
did not find any difference in the incidence of RDS between
the SGA and AGA groups. Consistent with our results,
several previous studies found no differences in the inci-
dence of RDS between the two groups,9,26 and some reports
even showed an increased incidence and severity of RDS in
premature SGA infants.27,28 Tyson et al28 emphasized that it
is important to compare the outcome of SGA and AGA in-
fants with the same gestational age. In their study, the
concept of intrauterine growth retardation on accelerating
lung maturation and improving outcome was not supported
by the comparison of SGA and AGA with the same gesta-
tional age, sex, and race. Interestingly, Zaw and co-
workers29 reported a higher incidence of RDS among SGA
infants with use of the fetal growth standard but no dif-
ference between SGA and AGA infants with use of the
neonatal growth standard. With the restrictions of our
database, we could only identify the RDS cases with the use
of surfactants and may therefore have lost many RDS cases
with mild presentation and no use of surfactants. We
speculate that the definition of RDS may be one of the
reasons that we did not find any difference in the incidence
of RDS between the SGA and AGA groups.
It is noteworthy that an increased risk of ROP was found
to be associated with SGA in the VLBW infants with a
gestational age of 27e32 weeks in this study. The associa-
tions between prenatal weight gain and ROP have not been
consistent in past studies. Garite et al3 showed in a large
population study that within each gestational age group
from 25 weeks to 32 weeks, intrauterine growth restriction
was associated with an increased risk of ROP. However,
another study indicated that birth weight was not a sig-
nificant risk factor when including gestational age and
serum levels of insulin-like growth factor-I (IGF-I) inal) of outcome variables for the SGA group (the AGA group was
GA 27e29 weeks GA 24e26 weeks
264 113
528 226
1.31 (0.96e1.77) 0.72 (0.44e1.19)
1.19 (0.59e2.41) 0.94 (0.37e2.4)
1.71 (1.05e2.79) y 1.71 (0.67e2.13)
0.81 (0.45e1.46) 1.20 (0.67e2.14)
1.19 (0.62e2.31) 0.77 (0.27e2.2)
2.5 (1.69e3.71) x 1.87 (0.87e4.0)
3.21 (1.96e5.25) x 2.05 (1.18e3.55) y
nary dysplasia; GA Z gestational age; IPPV Z intermittent pos-
necrotizing enterocolitis; ORZ odds ratio; PVLZ periventricular
thy of prematurity; SGA Z small-for-gestational-age.
antenatal steroids.
d number of days of IPPV.
, and Apgar score at 5 minutes.
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that in addition to low gestational ages, both postnatal
birth weight gain and serum IGF-I levels during the first
weeks/months of life may be the strongest predictor of ROP
and correlated with the severity of ROP.31 Further studies
are needed to evaluate the association of poor prenatal
weight gain with ROP.
Our results show no evidence that SGA is associated with
increased risks of IVH or NEC. Similarly, most previous
studies found no differences in the incidence of IVH be-
tween SGA and AGA preterm neonates.22,32,33 However,
because several other studies contradict these findings,34
further research is needed to explore this issue. It is
believed that redistribution of blood flow in in utero growth
restriction leads to a brain sparing effect at the expense of
other organs and tissues, such as kidneys, muscles, or in-
testines.35,36 Intestinal ischemia could increase the sus-
ceptibility of SGA infants to developing NEC. Although our
present study found no difference in the incidence of NEC
between SGA and AGA infants, the results from previous
studies are contradictory, showing either a higher10,22 or a
similar incidence32 incidence of NEC in SGA infants.
The strength of our present study is that it is a large
multicenter cohort study, which allowed us to assess the
association between SGA and neonatal outcomes in
different gestational subgroups. However, our study has
some limitations. First, the reliability of our data depended
on the precision of pediatricians and case managers. Sec-
ond, our study group was limited to the VLBW neonates
with a gestational age of 24e32 weeks. Further research is
needed to access the impact of SGA on premature infants >
32 weeks. Third, we lacked sufficient prenatal data in the
database for the diagnosis of SGA according to the fetal
growth standard. Recent studies have emphasized that
fetal growth standards more reliably identify increased
risks of clinical outcomes among preterm SGA infants
compared to neonatal growth standards.29
In conclusion, our data provide evidence that SGA may
be associated with increased risks of neonatal death, ROP,
and BPD in VLBW infants.Conflicts of interest
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